KRAS p.G12C Mutant Advanced Solid Tumors
Oncology
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| anti pd-1/l1 | AMGEN INC (AMGN) |
Frequently asked questions
How many drugs are in development for KRAS p.G12C Mutant Advanced Solid Tumors?
BioSniper tracks 1 drug in development for KRAS p.G12C Mutant Advanced Solid Tumors across 1 company.
How many clinical trials target KRAS p.G12C Mutant Advanced Solid Tumors?
There are 1 clinical trial targeting KRAS p.G12C Mutant Advanced Solid Tumors tracked by BioSniper.
Deep-dive into KRAS p.G12C Mutant Advanced Solid Tumors
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis